Clinical outcomes of multifocal intraocular lenses in patients with Fuchs' endothelial corneal dystrophy

Session Details

Session Title: Multifocal IOLs II

Session Date/Time: Monday 16/09/2019 | 08:30-10:30

Paper Time: 09:56

Venue: Free Paper Forum: Podium 1

First Author: : M.Blau-Most ISRAEL

Co Author(s): :    O. Reitblat   A. Levy   E. Assia   G. Kleinmann                    

Abstract Details

Purpose:

To report the results of multifocal intraocular lenses (IOLs) implantation in patients with Fuchs endothelial corneal dystrophy (FECD).

Setting:

Ein-Tal Eye Center, Tel Aviv, Israel.

Methods:

A retrospective, case-control study of FECD patients that were implanted with multifocal/multifocal toric IOLs. The results were compared with a matched group of patients at a case-control ratio of 1:3. Endothelial cell count, uncorrected distance visual acuity (UCDVA), uncorrected intermediate visual acuity (UCIVA), uncorrected near visual acuity (UCNVA) and post-operative refraction were analyzed.

Results:

A total of 19 eyes of 10 patients with FECD were included in the study (mean endothelial cell count 1323.52±767.54 cells/mm2). No significant difference between FECD patients and the control group were found in the UCDVA (LogMAR) (mean 0.11±0.13 and 0.06±0.10, P=0.12, respectively), UCIVA (LogMAR) (mean 0.11±0.11 and 0.10±0.12, P=0.98, respectively) and post-operative refraction outcomes (mean spherical equivalent (SE) (D) 0.14±0.31 and -0.21±0.24, P=0.31, respectively).The UCNVA (LogMAR) was better among the FECD patients, 0.03±0.05 compared to 0.15±0.18 in the control group (P=0.009).

Conclusions:

Our results suggest that multifocal IOLs can be considered in patients with FECD, with clear corneas, that are not candidate for corneal transplantation.

Financial Disclosure:

None